The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The small insulinoma can not be detected by the CT or MRI. We use 68Ga-NOTA-exendin-4
positron emission tomography/computed tomography (PET/CT) to detect the insulinoma for the
patient diagnosed with endogenous hyperinsulinemic hypoglycaemia. And the diagnostic value
will be performed. A single dose of 37-111 Mega-Becquerel (MBq) 68Ga-NOTA-exendin-4 will be
injected intravenously. Visual and semiquantitative method will be used to assess the PET/CT
images.
Phase:
Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University